Suppr超能文献

患有抑郁症或焦虑症的成年人中不健康饮酒情况:COVID-19 期间的变化及其与心理健康治疗的关联

Unhealthy Alcohol Use Among Adults With Depression or Anxiety: Changes During COVID-19 and Associations With Mental Health Treatment.

作者信息

Satre Derek D, Palzes Vanessa A, Chi Felicia W, Kline-Simon Andrea H, Campbell Cynthia I, van Doren Natalia, Weisner Constance, Sterling Stacy

机构信息

Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California.

Division of Research, Kaiser Permanente Northern California, Pleasanton, California.

出版信息

J Stud Alcohol Drugs. 2024 Nov;85(6):920-926. doi: 10.15288/jsad.23-00373. Epub 2024 May 22.

Abstract

OBJECTIVE

Individuals with unhealthy alcohol use and comorbid depression or anxiety may be vulnerable to alcohol use escalation in times of stress such as the COVID-19 pandemic. Among a cohort of individuals with pre-pandemic unhealthy drinking, we compared changes in alcohol use by whether people had a depression or anxiety diagnosis and examined whether mental health treatment was related to these changes.

METHOD

Using electronic health record data from Kaiser Permanente Northern California, we analyzed drinking changes during the pandemic (3/1/2020-6/30/2022) among adults identified in primary care with unhealthy alcohol use (exceeding daily/weekly recommended limits) pre-pandemic (1/1/2019-2/29/2020). Outcomes were mean changes in number of heavy drinking days (prior 3 months), drinks/week, drinks/day, and drinking days/week. Multivariable linear regression models were fit to (a) compare outcomes of patients with depression or anxiety diagnoses to those without, and (b) among patients with depression or anxiety, estimate associations between mental health treatment and outcomes.

RESULTS

The sample included 62,924 adults with unhealthy alcohol use, of whom 12,281 (19.5%) had depression or anxiety. On average, alcohol use significantly decreased across all measures during the pandemic; however, patients with depression or anxiety had greater decreases in drinks/week (adjusted mean difference [aMD] [CI] = -0.34 [-0.55, -0.12]) and drinking days/week (-0.15 [-0.20, -0.10]). No associations were found between mental health treatment and changes in drinking.

CONCLUSIONS

Contrary to expectations, patients with unhealthy alcohol use and depression or anxiety decreased alcohol use more than those without depression or anxiety during COVID-19, regardless of whether they accessed mental health services.

摘要

目的

饮酒不健康且合并有抑郁症或焦虑症的个体,在面临诸如新冠疫情这样的压力时期,可能更容易出现饮酒量增加的情况。在一组疫情前饮酒不健康的个体中,我们比较了有或没有抑郁症或焦虑症诊断的人群在饮酒方面的变化,并研究了心理健康治疗与这些变化之间是否存在关联。

方法

利用北加利福尼亚凯撒医疗集团的电子健康记录数据,我们分析了在疫情期间(2020年1月3日至2022年6月30日),那些在初级保健中被确定为疫情前(2019年1月1日至2020年2月29日)饮酒不健康(超过每日/每周推荐限量)的成年人的饮酒变化情况。观察指标为重度饮酒天数(过去3个月)、每周饮酒量、每日饮酒量和每周饮酒天数的平均变化。采用多变量线性回归模型来(a)比较有抑郁症或焦虑症诊断的患者与无此类诊断患者的观察指标,以及(b)在有抑郁症或焦虑症的患者中,评估心理健康治疗与观察指标之间的关联。

结果

样本包括62924名饮酒不健康的成年人,其中12281人(19.5%)患有抑郁症或焦虑症。总体而言,疫情期间所有指标的饮酒量均显著下降;然而,患有抑郁症或焦虑症的患者每周饮酒量(调整后平均差值[aMD][CI]=-0.34[-0.55,-0.

相似文献

6
Baclofen for alcohol use disorder.巴氯芬治疗酒精使用障碍。
Cochrane Database Syst Rev. 2023 Jan 13;1(1):CD012557. doi: 10.1002/14651858.CD012557.pub3.
8
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验